1	Interferon-gamma	Interferon-gamma	_	_	_	_	_	_	_
2	potentiates	potentiate	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	antiviral	antiviral	_	_	_	_	_	_	_
5	activity	activity	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	expression	expression	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	interferon-stimulated	interferon-stimulated	_	_	_	_	_	_	_
11	genes	gene	_	_	_	_	_	_	_
12	induced	induce	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	interferon-alpha	interferon-alpha	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	U937	u937	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Binding	binding	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	type	type	_	_	_	_	_	_	_
4	I	i	_	_	_	_	_	_	_
5	interferon	interferon	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	IFN-alpha/beta	IFN-alpha/beta	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	specific	specific	_	_	_	_	_	_	_
11	receptors	receptor	_	_	_	_	_	_	_
12	results	result	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	rapid	rapid	_	_	_	_	_	_	_
16	transcriptional	transcriptional	_	_	_	_	_	_	_
17	activation	activation	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	independent	independent	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	protein	protein	_	_	_	_	_	_	_
22	synthesis	synthesis	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	IFN-alpha-stimulated	ifn-alpha-stimulated	_	_	_	_	_	_	_
26	genes	gene	_	_	_	_	_	_	_
27	(	(	_	_	_	_	_	_	_
28	ISGs	ISG	_	_	_	_	_	_	_
29	)	)	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	human	human	_	_	_	_	_	_	_
32	fibroblasts	fibroblast	_	_	_	_	_	_	_
33	and	and	_	_	_	_	_	_	_
34	HeLa	HeLa	_	_	_	_	_	_	_
35	and	and	_	_	_	_	_	_	_
36	Daudi	Daudi	_	_	_	_	_	_	_
37	cell	cell	_	_	_	_	_	_	_
38	lines	line	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	binding	binding	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	ISGF3	ISGF3	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	IFN-stimulated	ifn-stimulated	_	_	_	_	_	_	_
7	gene	gene	_	_	_	_	_	_	_
8	factor	factor	_	_	_	_	_	_	_
9	3	3	_	_	_	_	_	_	_
10	)	)	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	conserved	conserve	_	_	_	_	_	_	_
14	IFN-stimulated	ifn-stimulated	_	_	_	_	_	_	_
15	response	response	_	_	_	_	_	_	_
16	element	element	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	ISRE	ISRE	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	results	result	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	transcriptional	transcriptional	_	_	_	_	_	_	_
23	activation	activation	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	factor	factor	_	_	_	_	_	_	_
3	is	be	_	_	_	_	_	_	_
4	composed	compose	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	DNA-binding	dna-binding	_	_	_	_	_	_	_
8	protein	protein	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	ISGF3	isgf3	_	_	_	_	_	_	_
11	gamma	gamma	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	which	which	_	_	_	_	_	_	_
15	normally	normally	_	_	_	_	_	_	_
16	is	be	_	_	_	_	_	_	_
17	present	present	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	cytoplasm	cytoplasm	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	other	other	_	_	_	_	_	_	_
24	IFN-alpha-activated	ifn-alpha-activated	_	_	_	_	_	_	_
25	proteins	protein	_	_	_	_	_	_	_
26	which	which	_	_	_	_	_	_	_
27	preexist	preexist	_	_	_	_	_	_	_
28	as	as	_	_	_	_	_	_	_
29	latent	latent	_	_	_	_	_	_	_
30	cytoplasmic	cytoplasmic	_	_	_	_	_	_	_
31	precursors	precursor	_	_	_	_	_	_	_
32	(	(	_	_	_	_	_	_	_
33	ISGF3	isgf3	_	_	_	_	_	_	_
34	alpha	alpha	_	_	_	_	_	_	_
35	)	)	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	found	find	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	ISG	ISG	_	_	_	_	_	_	_
6	expression	expression	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	monocytic	monocytic	_	_	_	_	_	_	_
10	U937	u937	_	_	_	_	_	_	_
11	cell	cell	_	_	_	_	_	_	_
12	line	line	_	_	_	_	_	_	_
13	differs	differ	_	_	_	_	_	_	_
14	from	from	_	_	_	_	_	_	_
15	most	most	_	_	_	_	_	_	_
16	cell	cell	_	_	_	_	_	_	_
17	lines	line	_	_	_	_	_	_	_
18	previously	previously	_	_	_	_	_	_	_
19	examined	examine	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	U937	u937	_	_	_	_	_	_	_
2	cells	cell	_	_	_	_	_	_	_
3	express	express	_	_	_	_	_	_	_
4	both	both	_	_	_	_	_	_	_
5	type	type	_	_	_	_	_	_	_
6	I	i	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	type	type	_	_	_	_	_	_	_
9	II	ii	_	_	_	_	_	_	_
10	IFN	IFN	_	_	_	_	_	_	_
11	receptors	receptor	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	but	but	_	_	_	_	_	_	_
14	only	only	_	_	_	_	_	_	_
15	IFN-alpha	IFN-alpha	_	_	_	_	_	_	_
16	is	be	_	_	_	_	_	_	_
17	capable	capable	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	inducing	induce	_	_	_	_	_	_	_
20	antiviral	antiviral	_	_	_	_	_	_	_
21	protection	protection	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	these	these	_	_	_	_	_	_	_
24	cells	cell	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	Pretreatment	Pretreatment	_	_	_	_	_	_	_
2	with	with	_	_	_	_	_	_	_
3	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
4	potentiates	potentiate	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	IFN-alpha-induced	ifn-alpha-induced	_	_	_	_	_	_	_
7	protection	protection	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	but	but	_	_	_	_	_	_	_
10	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
11	alone	alone	_	_	_	_	_	_	_
12	does	do	_	_	_	_	_	_	_
13	not	not	_	_	_	_	_	_	_
14	have	have	_	_	_	_	_	_	_
15	any	any	_	_	_	_	_	_	_
16	antiviral	antiviral	_	_	_	_	_	_	_
17	activity	activity	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	ISG15	ISG15	_	_	_	_	_	_	_
2	mRNA	mRNA	_	_	_	_	_	_	_
3	accumulation	accumulation	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	U937	u937	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	not	not	_	_	_	_	_	_	_
9	detectable	detectable	_	_	_	_	_	_	_
10	before	before	_	_	_	_	_	_	_
11	6	6	_	_	_	_	_	_	_
12	h	h	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	IFN-alpha	IFN-alpha	_	_	_	_	_	_	_
15	treatment	treatment	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	peaks	peak	_	_	_	_	_	_	_
18	at	at	_	_	_	_	_	_	_
19	24	24	_	_	_	_	_	_	_
20	h	h	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	requires	require	_	_	_	_	_	_	_
24	protein	protein	_	_	_	_	_	_	_
25	synthesis	synthesis	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Although	although	_	_	_	_	_	_	_
2	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
3	alone	alone	_	_	_	_	_	_	_
4	does	do	_	_	_	_	_	_	_
5	not	not	_	_	_	_	_	_	_
6	induce	induce	_	_	_	_	_	_	_
7	ISG	ISG	_	_	_	_	_	_	_
8	expression	expression	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
11	pretreatment	pretreatment	_	_	_	_	_	_	_
12	markedly	markedly	_	_	_	_	_	_	_
13	increases	increase	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	hastens	hasten	_	_	_	_	_	_	_
16	ISG	isg	_	_	_	_	_	_	_
17	expression	expression	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	transcriptional	transcriptional	_	_	_	_	_	_	_
20	induction	induction	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Nuclear	nuclear	_	_	_	_	_	_	_
2	extracts	extract	_	_	_	_	_	_	_
3	assayed	assay	_	_	_	_	_	_	_
4	for	for	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	presence	presence	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	ISRE	ISRE	_	_	_	_	_	_	_
9	binding	binding	_	_	_	_	_	_	_
10	factors	factor	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	electrophoretic	electrophoretic	_	_	_	_	_	_	_
13	mobility	mobility	_	_	_	_	_	_	_
14	shift	shift	_	_	_	_	_	_	_
15	assays	assay	_	_	_	_	_	_	_
16	show	show	_	_	_	_	_	_	_
17	that	that	_	_	_	_	_	_	_
18	ISGF3	isgf3	_	_	_	_	_	_	_
19	is	be	_	_	_	_	_	_	_
20	induced	induce	_	_	_	_	_	_	_
21	by	by	_	_	_	_	_	_	_
22	IFN-alpha	IFN-alpha	_	_	_	_	_	_	_
23	within	within	_	_	_	_	_	_	_
24	6	6	_	_	_	_	_	_	_
25	h	h	_	_	_	_	_	_	_
26	from	from	_	_	_	_	_	_	_
27	undetectable	undetectable	_	_	_	_	_	_	_
28	basal	basal	_	_	_	_	_	_	_
29	levels	level	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	untreated	untreated	_	_	_	_	_	_	_
32	U937	u937	_	_	_	_	_	_	_
33	cells	cell	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	Activation	Activation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	ISGF3	isgf3	_	_	_	_	_	_	_
4	alpha	alpha	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	latent	latent	_	_	_	_	_	_	_
8	component	component	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	ISGF3	ISGF3	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	occurs	occur	_	_	_	_	_	_	_
13	rapidly	rapidly	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	increase	increase	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	ISGF3	isgf3	_	_	_	_	_	_	_
7	activity	activity	_	_	_	_	_	_	_
8	ultimately	ultimately	_	_	_	_	_	_	_
9	correlates	correlate	_	_	_	_	_	_	_
10	with	with	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	accumulation	accumulation	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	ISGF3	isgf3	_	_	_	_	_	_	_
15	gamma	gamma	_	_	_	_	_	_	_
16	induced	induce	_	_	_	_	_	_	_
17	by	by	_	_	_	_	_	_	_
18	IFN-alpha	IFN-alpha	_	_	_	_	_	_	_
19	or	or	_	_	_	_	_	_	_
20	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	(	(	_	_	_	_	_	_	_
2	ABSTRACT	abstract	_	_	_	_	_	_	_
3	TRUNCATED	truncated	_	_	_	_	_	_	_
4	AT	at	_	_	_	_	_	_	_
5	250	250	_	_	_	_	_	_	_
6	WORDS	words	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_

